Ultimovacs Receives Notice of Allowance on US Patent on Vaccine-Checkpoint Inhibitor Combinations
Extends protection for UV1 vaccine-checkpoint inhibitor combinations until at least 2037Covers UV1 with CTLA-4, PD-1 or PD-L1 checkpoint inhibitorsOslo, 22...